How genetically engineered mouse tumor models provide insights into human cancers.
Genetically engineered mouse models (GEMMs) of human cancer were first created nearly 30 years ago. These early transgenic models demonstrated that mouse cells could be transformed in vivo by expression of an oncogene. A new field emerged, dedicated to generating and using mouse models of human cancer to address a wide variety of questions in cancer biology. The aim of this review is to highlight the contributions of mouse models to the diagnosis and treatment of human cancers. Because of the breadth of the topic, we have selected representative examples of how GEMMs are clinically relevant rather than provided an exhaustive list of experiments. Today, as detailed here, sophisticated mouse models are being created to study many aspects of cancer biology, including but not limited to mechanisms of sensitivity and resistance to drug treatment, oncogene cooperation, early detection, and metastasis. Alternatives to GEMMs, such as chemically induced or spontaneous tumor models, are not discussed in this review.
Memorial Sloan-Kettering Cancer Center, New York, NY, USA. katerina.politi@yale.edu
Katerina
K
Politi
William
W
Pao
D000818:Animals; D004195:Disease Models, Animal; D005818:Genetic Engineering; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009369:Neoplasms / Q000235:genetics*
Nature. 2009 Nov 5;462(7269):104-7
19847165
Mamm Genome. 2002 Oct;13(10):543-7
12420130
Nat Biotechnol. 2010 Jan;28(1):71-8
20023657
Nat Protoc. 2009;4(7):1064-72
19561589
Nature. 2010 Jan 14;463(7278):184-90
20016488
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2359-64
19174523
Cancer Res. 2005 Nov 15;65(22):10280-8
16288016
Nature. 2009 Sep 17;461(7262):411-4
19727076
Science. 2002 Jul 5;297(5578):63-4
12098689
Cancer Prev Res (Phila). 2009 Mar;2(3):224-33
19240248
N Engl J Med. 2010 Aug 26;363(9):809-19
20818844
Cancer Res. 2010 Dec 1;70(23):9827-36
20952506
Nature. 2007 Feb 8;445(7128):661-5
17251932
Cancer Prev Res (Phila). 2009 Apr;2(4):330-7
19336729
Cell. 2003 Mar 21;112(6):831-43
12654249
Science. 2009 Jun 12;324(5933):1457-61
19460966
Cancer Cell. 2010 Jan 19;17(1):98-110
20129251
N Engl J Med. 2002 Feb 28;346(9):645-52
11870241
Cancer Cell. 2002 Aug;2(2):117-25
12204532
Nat Genet. 1993 Nov;5(3):225-9
8275085
J Nucl Med. 2008 Mar;49(3):422-9
18287265
Nature. 2010 Jan 14;463(7278):191-6
20016485
Genes Dev. 2005 Mar 15;19(6):643-64
15769940
Nature. 2007 Aug 16;448(7155):807-10
17676035
Science. 2008 Sep 26;321(5897):1807-12
18772396
Nat Rev Cancer. 2007 Sep;7(9):659-72
17721431
Oncogene. 2004 Feb 26;23(8):1558-65
14661057
Cancer Res. 2007 May 15;67(10):4933-9
17510423
Mol Cell. 1999 May;3(5):565-77
10360173
Nature. 1999 Jul 29;400(6743):468-72
10440378
J Clin Oncol. 2005 Feb 10;23(5):939-52
15557593
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18351-6
19805051
Nature. 2009 Dec 24;462(7276):1070-4
20033049
Cancer Res. 2010 Mar 15;70(6):2485-94
20215504
Nature. 2008 Oct 23;455(7216):1069-75
18948947
Cancer Cell. 2008 Jan;13(1):58-68
18167340
PLoS One. 2009 Nov 19;4(11):e7916
19936259
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11
15329413
Cell. 2002 May 3;109(3):321-34
12015982
Gastroenterology. 2009 Mar;136(3):780-98
19263594
PLoS One. 2007 Aug 29;2(8):e810
17726540
Science. 2008 Sep 26;321(5897):1841-4
18755941
Nat Med. 2001 Feb;7(2):235-9
11175856
Genes Dev. 2003 Feb 15;17(4):488-501
12600942
PLoS Med. 2008 Jun 10;5(6):e123
18547137
Cancer Cell. 2007 Jul;12(1):81-93
17613438
Genes Dev. 2010 Apr 15;24(8):837-52
20395368
Nat Genet. 2007 Jul;39(7):914-21
17572676
Genes Dev. 2007 Feb 15;21(4):379-84
17299132
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16224-9
18852474
Cancer Metastasis Rev. 2010 Mar;29(1):123-42
20143131
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20932-7
18093943
Genes Dev. 2009 Jun 1;23(11):1327-37
19487573
Cell. 1984 Oct;38(3):627-37
6488314
Cancer Res. 2007 Aug 1;67(15):7378-85
17671208
Science. 2004 Jun 4;304(5676):1497-500
15118125
Oncogene. 2008 Aug 7;27(34):4702-11
18408761
Brain Tumor Pathol. 2009;26(2):43-50
19856214
Nat Med. 2008 Dec;14(12):1351-6
19029981
Annu Rev Genet. 1996;30:603-36
8982467
N Engl J Med. 2009 Sep 10;361(11):1058-66
19657110
Clin Cancer Res. 2005 Jun 1;11(11):4182-90
15930355
Dis Model Mech. 2010 Jan-Feb;3(1-2):111-9
20007486
J Clin Invest. 2009 Oct;119(10):3000-10
19759520
Brain Pathol. 2009 Jan;19(1):132-43
19076778
Nature. 2007 Dec 6;450(7171):893-8
17982442
Cell. 1984 Jun;37(2):367-79
6327063
Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5242-7
18356293
Science. 2007 May 18;316(5827):1039-43
17463250
Mol Cell. 1999 Aug;4(2):199-207
10488335
Lancet Oncol. 2010 Apr;11(4):350-7
20163987
PLoS Med. 2005 Mar;2(3):e73
15737014
N Engl J Med. 2004 May 20;350(21):2129-39
15118073
Genes Dev. 2007 Sep 15;21(18):2258-70
17875663
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19893-7
19064915
N Engl J Med. 2001 Apr 5;344(14):1031-7
11287972
Cell. 2006 Dec 29;127(7):1323-34
17182091
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):474-9
19122144
Cancer Cell. 2006 Jun;9(6):485-95
16730237
J Clin Invest. 2008 Jan;118(1):51-63
18060046
Genes Dev. 2006 Jun 1;20(11):1496-510
16705038
Mol Cell Biol. 2006 Nov;26(21):8109-21
16908535
Genes Dev. 2001 Dec 15;15(24):3249-62
11751631
Curr Biol. 1994 Jan 1;4(1):1-7
7922305
Nat Genet. 2009 May;41(5):544-52
19282848
Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19503-8
19850869
Cancer Res. 2008 Jul 15;68(14):5827-38
18632637